Status:
RECRUITING
Thoracoscopic Pleural Biopsy in Sohag University Hospital
Lead Sponsor:
Sohag University
Conditions:
Pleural Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Eligibility Criteria
Inclusion
- Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
- Age: Adults aged 18 years and older
- Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.
Exclusion
- Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
- Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
- Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
- Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
- Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons.
- Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06964308
Start Date
October 1 2024
End Date
May 30 2025
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University Hospital
Sohag, Egypt